Immunofluorescence results show a hyperglycemia environment can significantly reduce SIRT1 and SOD2 expression and increase ROS level as shown in Fig. 3A, C, and SIL intervention therapy can significantly increase SIRT1 and SOD2 expression, and decrease ROS level. This evidence concerns the gene SOD2 and Hyperglycemia.